Pre Market Game Plan by AJ – 01/27/2025

1) $AKRO Positive Phase 2 Clinical Data for Efruxiefermin (26.18) Stock Gapping UP +100% IMO do not long unless pop at the open to $58.75…

AwesomecallsTradingJanuary 27, 2025